|
APLS
|
US |
APELLIS PHARMACEUTICALS INC |
3,006,980 |
$96M |
15.79% |
-
|
- |
|
AVBP
|
US |
ARRIVENT BIOPHARMA INC |
2,059,387 |
$55M |
9.03% |
4.2%
|
- |
|
DNTH
|
US |
DIANTHUS THERAPEUTICS INC |
2,110,167 |
$46M |
7.57% |
20.8%
|
- |
|
CNTA
|
US |
CENTESSA PHARMACEUTICALS-ADR |
1,993,052 |
$33M |
5.49% |
-0.9%
|
- |
|
VRNA
|
US |
VERONA PHARMA PLC - ADR |
571,264 |
$27M |
4.37% |
-68.9%
|
- |
|
NUVB
|
US |
NUVATION BIO INC |
9,202,907 |
$24M |
4.03% |
-24.4%
|
- |
|
INSM
|
US |
INSMED INC |
332,000 |
$23M |
3.77% |
-24.0%
|
- |
|
COGT
|
US |
COGENT BIOSCIENCES INC |
2,763,000 |
$22M |
3.55% |
111.7%
|
- |
|
SRRK
|
US |
SCHOLAR ROCK HOLDING CORP |
488,000 |
$21M |
3.47% |
100.0%
|
- |
|
MNMD
|
US |
MIND MEDICINE MINDMED INC |
3,018,000 |
$21M |
3.46% |
-
|
- |
|
OCUL
|
US |
OCULAR THERAPEUTIX INC |
2,425,000 |
$21M |
3.41% |
-
|
- |
|
TSHA
|
US |
TAYSHA GENE THERAPIES INC |
10,450,000 |
$18M |
2.97% |
128.6%
|
- |
|
INSM
|
US |
INSMED INC |
250,000 |
$17M |
2.84% |
-24.0%
|
Call |
|
VRDN
|
US |
VIRIDIAN THERAPEUTICS INC |
870,000 |
$17M |
2.74% |
-
|
- |
|
GOSS
|
US |
GOSSAMER BIO INC |
18,350,000 |
$17M |
2.73% |
99.7%
|
- |
|
DYN
|
US |
DYNE THERAPEUTICS INC |
668,000 |
$16M |
2.59% |
154.3%
|
- |
|
PHVS
|
US |
PHARVARIS NV |
778,000 |
$15M |
2.45% |
25.4%
|
- |
|
CRBP
|
US |
CORBUS PHARMACEUTICALS HOLDI |
1,115,000 |
$13M |
2.17% |
-
|
- |
|
MRUS
|
US |
MERUS NV |
308,000 |
$13M |
2.13% |
100.0%
|
- |
|
ERAS
|
US |
ERASCA INC |
5,136,795 |
$13M |
2.12% |
100.0%
|
- |